Investor-State Dispute Settlement in EU-US Trade Deal Risks Access to Affordable Medicines

BRUSSELS—Several European and American health NGOs publicly criticised the inclusion of investor-state dispute settlement (ISDS) in the Transatlantic Trade and Investment Partnership (TTIP) today, warning that it will undermine public health policies of European Union (EU) Member States and severely jeopardise access to affordable medicines and public health protection.

Read more…

START TYPING AND PRESS ENTER TO SEARCH